Skip to Content

September 15, 2017, 12:45 PM

Congress has been locked in debate over the last year about repealing the Affordable Care Act. There have been numerous controversies over the process used, as well as the outcome achieved. Panelists reflected on the changes and the rhetoric that have emerged around health and the government's role in providing a safety net. How should elected representatives weigh the short-term and long-term health care needs of their constituents in these contexts? What were the roles that health care providers and patients played in the debate, and how could they have been more effective?

Panelists

Register

This event was free and open to the public, but registration was required.

Learn more about the Health Policy and Bioethics Consortia.

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. They are organized by the Center for Bioethics at Harvard Medical School and the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.

Tags

bioethics   doctor patient relationship   health care finance   health care reform   health law policy   health policy and bioethics consortia   insurance   medicare-medicaid   public health   regulation